Zhang_X 2009.
Study characteristics | |||
Patient sampling | No information provided | ||
Patient characteristics and setting | 88 children; China; no further info Little information provided; no inclusion criteria given; department not reported Representative spectrum? Unclear: no information provided except that they were children |
||
Index tests | Platelia test, but not used as a standard care procedure. Cut‐off single sample 0.5 | ||
Target condition and reference standard(s) | Criteria of the Editorial Board of the Chinese Journal of Medicine Incorporation avoided? Yes, Platelia explicitly excluded from criteria Acceptable reference standard? Unclear: Chinese criteria and only 3 categories |
||
Flow and timing | Time interval not reported Partial verification avoided? Yes Withdrawals explained? Not reported Uninterpretable results reported? Not reported |
||
Comparative | |||
No patients per category | 14 proven/probable; 16 possible; 58 no IA | ||
Notes | Sponsored by Platelia Chinese language |
||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Unclear | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Unclear | Unclear | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Low | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Unclear | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Unclear | Unclear | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Unclear | ||
Unclear |
IFD: Invasive Fungal Disease; IFI: Invasive Fungal Infection; IPA: Invasive Pulmonary Aspergillosis; BAL: bronchoalveolar lavage; BMT: bone marrow transplantation; COI: conflict of interest; COPD: chronic obstructive pulmonary disease; CT: computerised tomography; ELISA: enzyme‐linked immunosorbent assay; EIA: enzyme immuno‐assay (equals ELISA); EORTC: European Organization for Research and Treatment of Cancer; GM: galactomannan; HSCT: haematopoietic stem cell transplantation; IA: invasive aspergillosis; ICU: intensive care unit; MSG: Mycoses Study Group; N/A: not applicable; NR: not reported; ODI: optical density index; PCR: polymerase chain reaction; ROC: receiver operating characteristic; SCT: stem cell transplantation; WBC: white blood cells.